2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased morbidity and mortality. Dronedarone is a recent antiarrhythmic drug that has been developed for treatment of AF, with electrophysiological properties similar to amiodarone but with a lower incidence of side effects.

          Related collections

          Author and article information

          Journal
          Expert Opin Drug Metab Toxicol
          Expert opinion on drug metabolism & toxicology
          Informa Healthcare
          1744-7607
          1742-5255
          Dec 2014
          : 10
          : 12
          Affiliations
          [1 ] IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Department of Cardiology , Largo R. Benzi 1 16132 Genoa , Italy.
          Article
          10.1517/17425255.2014.974551
          25349898
          d4b556b9-fd21-4767-b301-45f21e36f7d4
          History

          atrial fibrillation,amiodarone,antiarrhythmic therapy,atrial flutter,dronedarone

          Comments

          Comment on this article